Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-04-01 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | AI Server · Automotive Mix Improvement · FC-BGA / 2025-08-26 RESEARCH
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Paid-in Capital Increase / 2026-03-04 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Acquisition of Shares and Equity Securities of Other Corporations / 2025-11-24 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Compliance Program Operation Status / 2024-04-25 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Decision on Provision of Debt Guarantee for Others / 2026-03-27 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Advance Notice of Earnings Release / 2024-01-10 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – (Correction) Decision on Paid-in Capital Increase / 2025-12-23 Disclosures

[Disclosure] Hanwha Systems (272210) – (Correction) Decision on Guarantees for Others / 2025-01-15

Posted on January 15, 2025August 11, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Systems has finalized the guarantee period (January 15, 2025 – January 15, 2026) for its debt guarantee decision of KRW 55.79B (USD 40M) to back operational fund borrowings by its affiliated company, Philly Shipyard Inc.

📊 [Key Disclosure Details & Financial Highlights]

  1. Correction Overview
  • Correction Date: January 15, 2025
  • Original Filing & Date: Decision on Guarantees for Others (November 29, 2024)
  • Reason for Correction: Confirmation of the debt guarantee period
  1. Main Corrected Details
  • Debt Guarantee Period:
    • Before: Not specified (-) (Scheduled for 12 months from initial agreement)
    • After: January 15, 2025 ~ January 15, 2026
  • Revision of Other Important Matters: Deletion of preliminary condition clauses (“Subject to completion of PSI acquisition process”)
  1. Detailed Debt Guarantee Terms
  • Debtor: Philly Shipyard Inc. (Relationship: Affiliated Company)
  • Creditor: Woori America Bank
  • Guaranteed Debt Amount: KRW 55,788,000,000 (USD 40,000,000 / Exchange rate of KRW 1,394.70/USD applied)
  • Total Equity (as of end-2023 Consolidated): KRW 2,154,126,164,004
  • Guarantee-to-Equity Ratio: 2.59%
  • Total Outstanding Debt Guarantee Balance: KRW 55,788,000,000
  • Board Resolution Date: November 29, 2024 (3 Outside Directors present)
  1. Debtor Financial Summary (Philly Shipyard Inc. / End-2023 / Unit: KRW M)
  • Total Assets: KRW 417,644M / Total Liabilities: KRW 371,825M / Total Equity: KRW 45,819M
  • Revenue: KRW 576,789M / Net Loss: -KRW 86,302M
  1. Other Important Matters
  • This disclosure pertains to a corporate guarantee for new local operating borrowings of Philly Shipyard Inc., acquired via subsidiary HS USA Holdings Corp.
  • KRW values remain subject to change depending on exchange rate fluctuations.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Debt Guarantee Fulfillment and Condition Changes

This disclosure reports the finalization of the guarantee period (Jan 15, 2025 – Jan 15, 2026) regarding the debt guarantee for operating capital borrowings of Philly Shipyard Inc. Verifying the debtor’s debt servicing performance during the confirmed guarantee period and checking for any subsequent adjustments to the guarantee terms serve as key follow-up checkpoints. Related progress can be reviewed in future periodic filings.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official filings from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] ALTEOGEN (196170) – Non-Designation as Unfaithful Disclosure Corporation (2 Cases of Disclosure Reversal) / 2025-01-15
Next Post: [Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase (Correction) / 2025-01-15

Related Posts

  • [Disclosure] KEPCO (015760 / KEP) – Filing of Lawsuit (Claims Exceeding Certain Amount) / 2025-05-07 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Advance Notice of Earnings Release / 2026-01-08 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Clarification on Rumors or News Reports / 2025-08-27 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Decision on Merger / 2024-11-07 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Provisional Operating Results (Consolidated) / 2025-07-25 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Decision on Cash/In-Kind Dividend / 2025-02-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Earnings Release (Provisional) / 2026-02-04 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P51 (Keytruda Biosimilar) U.S. Phase 3 Clinical Trial Plan Amendment Filing / 2026-07-06 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Capital Increase by Subsidiary / 2025-02-18 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Approval of Domestic Marketing Authorization for Tergase Injection (ALT-BB4) / 2024-07-05 Disclosures
  • [Disclosure] Hana Micron (067310) – Resolution on Convening General Meeting of Shareholders / 2025-05-21 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Pre-announcement of Financial Results / 2024-11-08 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Results of General Shareholders’ Meeting / 2026-03-26 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in Europe (Part 1 & 2) / 2024-10-14 Bio & Healthcare

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme